evoke trial semaglutide GLP-1 Fails to Outperform Placebo in Phase 3 of Alzheimer Disease | NeurologyLive Novo Nordisk Alzheimer's drug trials
Pay in 4 interest-free payments of $5.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26





















